Four investors. Four different questions.
A venture fund, a growth investor, a private-equity buyer and a strategic buyer can look at the same chemicals company and need four different answers. We read the company's own filings and the markets it sells into, and answer the question you are actually asking.
What each of you is really buying.
- Venture capital
- Can the technology reach commercial scale fast enough, and will somebody buy the company when it gets there?
- Growth equity
- Is the growth repeatable without a step change in technology?
- Private equity
- Does the business still earn this margin at the bottom of a cycle, and who pays a higher multiple in five years?
- Strategic and sovereign buyers
- Does the business sit behind walls that keep it earning and growing?
The screen, then the decision.
The screen
Give us a company's name. We look up what it has filed, what it makes, and the markets those chemicals sell into. Every answer comes with the document it came from.
The decision
For a deal under way, we add what the company and its advisers have given you, read it against those markets, and set out what the record supports for your kind of investor.
What we do not do. We never invent a figure. Where the record is silent we say so, and any assumption we make is labelled as ours, shown beside what the record supports. The judgement is yours, made with a chemist who spent 30 years in the industry.
Would it have warned you?
We read twelve past chemical deals and listings using only what each company had filed the day before. 3 caught, 3 missed, 1 false alarm, 5 clear.
Weighing a chemicals business?
Tell us the company's name. Clients read their screens and decisions behind the Client login.